BackNovavax Overview

Novavax Gross Profit

Gross Profit analysis for NVAX.

Quarterly Gross Profit

$108.82M
83.32% YoY

As of Mar 31, 2026

Annual Gross Profit (TTM)

$506.72M
53.82% YoY

Trailing 12 months ending Mar 31, 2026

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)